Definitive intensity-modulated radiation therapy for nasopharyngeal carcinoma: Long-term outcome of a multicenter prospective study

Journal of Cancer Research and Clinical Oncology

Volumn 139, Issue 1, 2013, Pages 139-145

  Wang, Rensheng ^a   Wu, Fang ^a   Lu, Heming ^b   Wei, Bo ^a   Feng, Guosheng ^b   Li, Guisheng ^c   Liu, Meilian ^d   Yan, Haolin ^e   Zhu, Jinxian ^f   Zhang, Yong ^a   Hu, Kai ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

^b PEOPLE'S HOSPITAL OF GUANGXI ZHUANG AUTONOMOUS REGION   (China)

^c Liuzhou Worker Hospital   (China)

^d GUILIN MEDICAL UNIVERSITY   (China)

^e First People's Hospital of Yulin City   (China)

^f Wuzhou Red Cross Hospital   (China)

Author keywords

Clinical outcome; Concurrent chemoradiotherapy; Intensity modulated radiotherapy; Nasopharyngeal carcinoma; Prospective study

Indexed keywords

CISPLATIN;

ADULT; ADVERSE OUTCOME; ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CLINICAL TRIAL; CRANIAL NERVE PARALYSIS; DISEASE SEVERITY; DISTANT METASTASIS; DISTANT METASTASIS FREE SURVIVAL; DRUG EFFICACY; FEMALE; FOLLOW UP; HEARING IMPAIRMENT; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; NASOPHARYNX CARCINOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DERMATITIS; RADIATION NECROSIS; SKIN FIBROSIS; SURVIVAL TIME; TREATMENT FAILURE; TRISMUS; VISUAL IMPAIRMENT; XEROSTOMIA;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMORADIOTHERAPY; CISPLATIN; DERMATITIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MUCOSITIS; NASOPHARYNGEAL NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROSPECTIVE STUDIES; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT FAILURE; TREATMENT OUTCOME; XEROSTOMIA;

EID: 84872328335     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-012-1313-0     Document Type: Article

References (20)

1. Cheng JC, Chao KS, Low D (2001) Comparison of intensity-modulated radiation therapy (IMRT) treatment techniques for nasopharyngeal carcinoma. Int J Cancer 96:126-131
2. Han L, Lin S, Pan J et al (2010) Prognostic factors of 305 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy. Chin J Cancer 29:145-150
3. Kam MK, Chau RM, Suen J et al (2003) Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation. Int J Radiat Oncol Biol Phys 56:145-157
4. Kam MK, Leung SF, Zee B et al (2007) Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early stage nasopharyngeal carcinoma. J Clin Oncol 25:4873-4879
5. Kwong DL, Pow EH, Sham JS et al (2004) Intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: a prospective study on disease control and preservation of salivary function. Cancer 101:1584-1593
6. Kwong DL, Sham JS, Leung LH et al (2006) Preliminary results of radiation dose escalation for locally advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 64:374-381
7. Lai SZ, Li WF, Chen L et al (2011) How does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients? Int J Radiat Oncol Biol Phys 80:661-668
8. Lee N, Xia P, Quivey JM et al (2002) Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys 53:12-22
9. Lee SW, Back GM, Yi BY et al (2006) Preliminary results of a phase I/II study of simultaneous modulated accelerated radiotherapy for nondisseminated nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 65:152-160
10. Lee N, Harris J, Garden AS et al (2009) Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225. J Clin Oncol 27:3684-3690
11. Lin S, Pan J, Han L et al (2009) Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective series. Int J Radiat Oncol Biol Phys 75:1071-1078
12. Lu H, Peng L, Yuan X et al (2009) Concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: a treatment paradigm also applicable to patients in Southeast Asia. Cancer Treat Rev 35:345-353
13. Ng WT, Lee MCH, Hung WM et al (2011) Clinical outcomes and patterns of failure after intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 79:420-428
14. Pow EH, Kwong DL, McMillan AS et al (2006) Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys 66:981-991
15. Teo PM, Ma BB, Chan AT (2004) Radiation therapy for nasopharyngeal carcinoma-transition from two-dimensional to three-dimensional method. Radiother Oncol 73:163-172
16. Toledano I, Graff P, Serre A et al (2012) Intensity-modulated radiotherapy in head and neck cancer: results of the prospective study GORTEC 2004-03. Radiother Oncol 103:57-62
17. Wang J, Shi M, Hsia Y et al (2012) Failure patterns and survival in patients with nasopharyngeal carcinoma treated with intensity-modulated radiation in Northwest China: a pilot study. Radiat Oncol 7:2
18. Wu S, Xie CY, Jin X et al (2006) Simultaneous modulated accelerated radiation therapy in the treatment of nasopharyngeal carcinoma; a local center's experience. Int J Radiat Oncol Biol Phys 66:S40-S46
19. Xia P, Fu KK, Wong GW et al (2000) Comparison of treatment plans involving intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 48:329-337
20. Zhao C, Lu L, Han F et al (2005) Preliminary results of intensity-modulated radiation therapy alone for 122 patients with untreated nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 63:S382